Pharma Journalist - Page 91 of 946 -

Fulcrum and Slate Medicines Agree to $245 Million Merger

LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases

Sandoz and Henlius Expand Global Biosimilar Collaboration

ImmunityBio Gets FDA Expanded Access for ANKTIVA in Solid Tumors

Sanofi to Acquire Blueprint Medicines, Boosting Rare Disease and Immunology Pipeline

Itepekimab Hits Primary Goal in One of Two COPD Phase 3 Trials

CirCode Biomed Gets FDA Clearance for First Circular RNA Drug HM2002

BioNTech, BMS Launch Global Partnership to Develop Cancer Therapy BNT327

Astellas Licenses XNW27011 ADC from Evopoint Biosciences

Teva’s Celiac Disease Drug Receives FDA Fast Track Designation

Biogen and City Therapeutics Launch Collaboration to Develop RNAi-Based Therapies

Coherus and STORM Therapeutics Partner to Evaluate STC-15 with LOQTORZI in Clinical Trial

AskBio Publishes Full Phase 1b Results for Parkinson’s Gene Therapy AB-1005